These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12391232)
1. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. Kjer-Nielsen L; Clements CS; Brooks AG; Purcell AW; Fontes MR; McCluskey J; Rossjohn J J Immunol; 2002 Nov; 169(9):5153-60. PubMed ID: 12391232 [TBL] [Abstract][Full Text] [Related]
2. A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule. Gras S; Wilmann PG; Chen Z; Halim H; Liu YC; Kjer-Nielsen L; Purcell AW; Burrows SR; McCluskey J; Rossjohn J J Immunol; 2012 Jan; 188(1):311-21. PubMed ID: 22140258 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558 [TBL] [Abstract][Full Text] [Related]
4. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584 [TBL] [Abstract][Full Text] [Related]
5. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Kjer-Nielsen L; Clements CS; Purcell AW; Brooks AG; Whisstock JC; Burrows SR; McCluskey J; Rossjohn J Immunity; 2003 Jan; 18(1):53-64. PubMed ID: 12530975 [TBL] [Abstract][Full Text] [Related]
6. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015 [TBL] [Abstract][Full Text] [Related]
8. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. Li L; Bouvier M J Immunol; 2004 May; 172(10):6175-84. PubMed ID: 15128805 [TBL] [Abstract][Full Text] [Related]
9. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope. Yang X; Chen G; Weng NP; Mariuzza RA J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605 [TBL] [Abstract][Full Text] [Related]
11. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows SR; Burrows JM; Moss DJ; Argaet VP; Misko IS J Exp Med; 1996 Nov; 184(5):1815-24. PubMed ID: 8920869 [TBL] [Abstract][Full Text] [Related]
12. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition. Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292 [TBL] [Abstract][Full Text] [Related]
13. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. Burrows SR; Khanna R; Burrows JM; Moss DJ J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682 [TBL] [Abstract][Full Text] [Related]
14. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype. Røder G; Blicher T; Justesen S; Johannesen B; Kristensen O; Kastrup J; Buus S; Gajhede M Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1300-10. PubMed ID: 17057332 [TBL] [Abstract][Full Text] [Related]
15. Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations. Stavrakoudis A Cell Biochem Biophys; 2011 Jul; 60(3):283-95. PubMed ID: 21253892 [TBL] [Abstract][Full Text] [Related]
16. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. Burrows SR; Kienzle N; Winterhalter A; Bharadwaj M; Altman JD; Brooks A J Immunol; 2000 Dec; 165(11):6229-34. PubMed ID: 11086057 [TBL] [Abstract][Full Text] [Related]
17. The shaping of T cell receptor recognition by self-tolerance. Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249 [TBL] [Abstract][Full Text] [Related]
18. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. Maenaka K; Maenaka T; Tomiyama H; Takiguchi M; Stuart DI; Jones EY J Immunol; 2000 Sep; 165(6):3260-7. PubMed ID: 10975842 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. Li H; Natarajan K; Malchiodi EL; Margulies DH; Mariuzza RA J Mol Biol; 1998; 283(1):179-91. PubMed ID: 9761682 [TBL] [Abstract][Full Text] [Related]
20. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. Reid SW; McAdam S; Smith KJ; Klenerman P; O'Callaghan CA; Harlos K; Jakobsen BK; McMichael AJ; Bell JI; Stuart DI; Jones EY J Exp Med; 1996 Dec; 184(6):2279-86. PubMed ID: 8976183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]